Search

everythinglearnresearchcommunity

for

Search:↓

Certain gene variations may increase the risk of alopecia, and platelet-rich plasma treatment can improve hair density in those with hair loss; a rare case of facial Becker's nevus was linked to uneven beard growth.

EGF and FGF help hair growth by affecting cell differentiation and fiber growth.

Growth factors are crucial for hair development and could help treat hair diseases.

VEGF stimulates hair cell growth and increases growth receptor levels through a specific signaling pathway.

Activating Nrf2 in skin cells speeds up wound healing by increasing the growth of certain stem cells.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

Baicalin may help treat hair loss by promoting hair follicle growth and activating specific cellular pathways.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Cross-section trichometry is an accurate method to measure hair loss and growth.

Collagen XVII is crucial for skin cell growth and nail health.

Targeted cancer therapies often cause serious skin problems that need careful management.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

EGFR helps control how hair grows and forms without needing p53 protein.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

A certain type of skin cell, marked by EGFR, produces a lot of IGF1 and helps hair follicles grow back faster.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

Intermittent isotretinoin can cause various skin, hair, and nail changes.

EGF and KGF signalling prevent hair follicle formation and promote skin cell development in mice.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

The study found that androgen receptors in skin cells mainly affect the focal adhesion pathway and control the caveolin-1 gene, with implications for new treatments for related diseases.

Blocking mTORC1 may help prevent skin cancer by stopping the growth of certain skin stem cells.

Understanding hair growth involves complex interactions between molecules and could help treat hair disorders.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.